KYNTRA BIO, INC. (KYNB) Shareholders’ equity 2016–2025
KYNTRA BIO, INC. (KYNB) shareholders’ equity at each fiscal year-end, per SEC filings.
-$30.0MFY2025 · since FY2016: $155.8M → -$30.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$30.0M | +86.7% |
| FY2024 | -$225.6M | -10.5% |
| FY2023 | -$204.2M | -852.0% |
| FY2022 | -$21.4M | -110.3% |
| FY2021 | $209.1M | -50.5% |
| FY2020 | $422.2M | -18.2% |
| FY2019 | $516.1M | +1.4% |
| FY2018 | $509.2M | -3.6% |
| FY2017 | $528.5M | +239.1% |
| FY2016 | $155.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice